INMED PHARMACEUTICALS INC. (INM) Gross margin 2022–2025
INMED PHARMACEUTICALS INC. (INM) gross margin by fiscal year — reported gross profit divided by reported revenue.
34.5%FY2025 · since FY2022: 39.8% → 34.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 34.5% | +10.6 pp |
| FY2024 | 23.9% | -10.0 pp |
| FY2023 | 33.9% | -5.9 pp |
| FY2022 | 39.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice